Nearly half a million Americans still acquire an infection during a hospital stay each year — a figure that demands attention even as the trend moves in a meaningful direction. A decade of infection control investment, policy pressure, and clinical protocol reform has produced a measurable, statistically robust reduction in one of medicine's most preventable harms, and this large national survey quantifies exactly how far the system has come.
Drawing on data from 218 hospitals across 10 CDC Emerging Infections Program sites, this 2023 prevalence survey found that 2.6% of hospitalized patients had at least one healthcare-associated infection (HAI) on any given survey day — down from 3.2% in the equivalent 2015 survey. Among the 151 hospitals that participated in both waves, the adjusted risk ratio was 0.73, meaning patients faced roughly 27% lower odds of acquiring an infection compared to eight years prior. The estimated national burden stands at approximately 518,000 HAIs annually. Critically, about 60% of those infections were not linked to devices or invasive procedures, suggesting a substantial reservoir of infections arising from more diffuse transmission pathways — wound care, environmental contamination, or person-to-person spread — that targeted device-bundle interventions cannot fully address.
This trajectory continues a trend documented since the 2011 baseline, when 1 in 25 patients had an HAI; that figure improved to 1 in 31 by 2015, and now sits near 1 in 38. The consistent downward slope across three survey cycles lends credibility to the finding beyond what any single study could establish. However, several caveats deserve weight. Prevalence surveys capture a single-day snapshot and may undercount infections with shorter or longer clinical windows. The 2023 data collection window spanned only the warmer months (May–September), which could introduce seasonal bias. Most importantly, the COVID-19 pandemic period saw documented surges in certain HAI types — particularly CLABSI and VAE — meaning the 2023 figure reflects recovery from a peak, not necessarily linear progress. The device-independent majority of infections points to an underexplored frontier: behavioral, environmental, and microbiome-level interventions that go beyond checklist-driven bundle compliance. From a longevity-relevant perspective, HAIs disproportionately affect older adults and immunocompromised patients, making sustained reduction in this metric a genuine healthspan issue.